These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17138075)

  • 1. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
    Bae JS; Ki CS; Kim JW; Kim BJ
    J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.
    van der Sluijs BM; van Engelen BG; Hoefsloot LH
    Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
    Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
    Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
    Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation.
    Robinson DO; Hilton-Jones D; Mansfield D; Hildebrand GD; Marks S; Mechan D; Ramsay J
    Neuromuscul Disord; 2011 Nov; 21(11):809-11. PubMed ID: 21742497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families.
    Rodríguez M; Camejo C; Bertoni B; Braida C; Rodríguez MM; Brais B; Medici M; Roche L
    Neuromuscul Disord; 2005 Feb; 15(2):185-90. PubMed ID: 15694141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical-genealogic and molecular-genetic characteristics of oculopharyngeal muscular dystrophy in the Republic of Sakha (Yakutia)].
    Maksimova NR; Nikolaeva IA; Korotkov MN; Ikeuchi T; Onodera O; Nishizava M; Stepanova SK; Kurtanov KhA; Sukhomiasova AL; Nogovitsyna AN; Gurinova EE; Stepanov VA; Puzyrev VP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):52-60. PubMed ID: 18577936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
    Davies JE; Berger Z; Rubinsztein DC
    Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.
    Goh KJ; Wong KT; Nishino I; Minami N; Nonaka I
    Neuromuscul Disord; 2005 Mar; 15(3):262-4. PubMed ID: 15725589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.
    Robinson DO; Hammans SR; Read SP; Sillibourne J
    Hum Genet; 2005 Mar; 116(4):267-71. PubMed ID: 15645184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint.
    Van Der Sluijs BM; Hoefsloot LH; Padberg GW; Van Der Maarel SM; Van Engelen BG
    J Neurol; 2003 Nov; 250(11):1307-12. PubMed ID: 14648146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
    Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
    Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of the recessive oculopharyngeal muscular dystrophy phenotype.
    Semmler A; Kress W; Vielhaber S; Schröder R; Kornblum C
    Muscle Nerve; 2007 May; 35(5):681-4. PubMed ID: 17206657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation.
    Robinson DO; Wills AJ; Hammans SR; Read SP; Sillibourne J
    J Med Genet; 2006 May; 43(5):e23. PubMed ID: 16648376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of rare recessive oculopharyngeal muscular dystrophy (OPMD) coexisting with hereditary neuropathy with liability to pressure palsies (HNPP).
    Marsh EA; Robinson DO
    Clin Neurol Neurosurg; 2008 May; 110(5):525-8. PubMed ID: 18358598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.